One of the nation's
leading pharmaceutical research companies.
Lilly Corporate Center
Indianapolis, IN 46285
CEO: John Lechleiter
Stock Symbol: LLY
Eli Lilly is one of the nation's top pharmaceutical and research companies. Lilly is committed to developing products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. Products are sold in 125 countries.
The company purchased Novartis Animal Health for $5.4 billion. The deal was completed on January 1, 2015.
The company has research and development facilities in 8 countries, manufacturing plants in 13 countries.
Lilly has 10,700 employees working in the Indianapolis area and 21,918 outside the U.S.
Eli Lilly says it takes 10-15 years for
a new drug to be discovered and given to a patient at an average
cost of $800 million to $1.2 billion.
Here are the top drugs that Eli Lilly is
- Alimta® (pemetrexed, Lilly)
- Cialis® (tadalafil, Lilly)
- Cymbalta® (duloxetine hydrochloride, Lilly)
- Cyramza® (ramucirumab, Lilly)
- Effient® (prasugrel, Lilly)
- Evista® (raloxifene hydrochloride, Lilly)
- Forteo® (teriparatide of recombinant DNA origin injection, Lilly)
- Humalog® (insulin lispro injection of recombinant DNA origin, Lilly)
- Humulin® (human insulin of recombinant DNA origin, Lilly)
- Jardiance® (empagliflozin, Boehringer Ingelheim)
- Keytruda® (pembrolizumab, Merck)
- Opdivo® (nivolumab, Bristol-Myers Squibb Company)
- Sentinel® (lufenuron and milbemycin oxime, Virbac)
- Strattera® (atomoxetine hydrochloride, Lilly)
- Trajenta® (linagliptin, Boehringer Ingelheim)
- Trulicity™ (dulaglutide, Lilly)
- Zyprexa® (olanzapine, Lilly)
The U.S. Food and Drug Administration (FDA) recently approved and the company launched Cyramza® (ramucirumab) in combination with docetaxel, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with disease progression on or after platinum-based chemotherapy.
In 2014, Lilly reported revenues of $19.6 billion, down 15% from the previous year. Alimta was Lilly's highest selling drug with $2.79 billion in revenues followed by Humalog at $2.78 billion. Cialis generated $2.29 billion in revenues.
Net income overall was $2.39 billion in 2014. The company spent $4.73 billion in research and development in 2014, down 14%.
The company's patents on the drugs Cymbalta and Evista expired in 2014. Cymbalta was the company's top selling drug in 2013.
"While Lilly's fourth-quarter 2014 results continue to reflect the impact of patent expirations, we are moving to a period of growth led by diabetes, oncology and animal health," said John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer. "Despite the loss of significant revenue for Cymbalta and Evista following the expiration of our U.S. patents, we saw strong performance from many other products. At the same time, we made excellent progress with our innovation-based strategy, and we continue to advance our pipeline. Throughout the balance of this decade, we aim to drive revenue growth and expand margins as we offer new medicines to the people who need them."
The company was founded on May 10, 1876
by Colonel Eli Lilly in Indianapolis, IN. A 38-year-old pharmaceutical
chemist and a veteran of the U.S. Civil War, Colonel Lilly was
frustrated by the poorly prepared, often ineffective medicines
of his day. Consequently, he made these commitments to himself
and to society:
- He would found a company that manufactured pharmaceutical products
of the highest possible quality.
- His company would develop only medicines that would be dispensed
at the suggestion of physicians rather than by eloquent sideshow
- Lilly pharmaceuticals would be based on the best science of
Lilly acquired biopharmaceutical company ImClone Systems in 2008 for approximately $6.5 billion.
The company lost patent protection for Zyprexa in 2011, which was the top-selling medicine for Lilly with $4.6 billion in sales.
In 2011, the company launched Bydureon, a drug to treat Type 2 diabetes.
- Cash Compensation - Annual bonus
based on company performance
- 401(k) Savings Plan - Lilly guarantees a match of 50
cents for each dollar contributed up to six percent of your monthly
base salary. The company also has discretion to make an additional
matching contribution. The company's matching contribution is
invested in Lilly common stock. Full-vesting of contributions
after three years.
- Retirement - Company paid benefit plan
- Financial Planning
- Extended Disability Leave
- Life Insurance
- Flexible Spending Accounts
- Health Insurance
- Domestic Partner Benefits
- Prescription Drug Benefit
- Dental Insurance
- Long-term Care Insurance
- Employee Health Services
- Employee Assistance Program
- Lilly University
- Educational Assistance
- Vacations and Holidays - During your first year at Lilly,
you'll earn eight hours of vacation for each month of service.
The amount of your vacation time will increase every five years,
starting with 96 hours (12 days) per year and, by your 25th year
of service, culminating with 216 hours (27 days) per year. In
the year you complete 10 years of service and every five years
of service thereafter, you'll also receive 40 hours of recognition
vacation. Employees also can purchase up to 40 hours of additional
vacation time each year, and up to 80 hours of additional vacation
time in recognition years. Employees who don't want this much
vacation can trade up to 40 hours of vacation time, in four-hour
increments, for credits they can use to obtain other benefits.
Lilly also provides an average of nine paid holidays and an additional
annual year-end break for four of the working days between December
25 and January 1. Most calendar years, this totals 25 paid days
off your first full year at Lilly.
- Flexibility in the Workplace
- Time Savers - Business casual dress code, on-site cafeteria,
banking and postal services
- For your Family
- Fun and Fitness
- Community Support
Updated February 2, 2015